<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08806103500131</udiDi>
    <basicUdiDi>B-08806103500131</basicUdiDi>
    <tradeName>HyaleXo</tradeName>
    <deviceName>HyaleXo Sterile Absorbable Viscoelastic Solution (Sodium Hyaluronate Solution) for Arthritis</deviceName>
    <manufacturerName>YooYoung Pharmaceutical Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000017424</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>SPPR236 / FRPR236</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:37:50.197Z</lastUpdated>
  </row>
  <row>
    <udiDi>08806103500124</udiDi>
    <basicUdiDi>B-08806103500124</basicUdiDi>
    <tradeName>Atri Plus Inj.</tradeName>
    <deviceName>Atri Plus Inj. Sterile Absorbable Viscoelastic Solution (Sodium Hyaluronate Solution) for Arthritis</deviceName>
    <manufacturerName>YooYoung Pharmaceutical Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000017424</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ENPR236 / EPPR236</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:37:48.963Z</lastUpdated>
  </row>
  <row>
    <udiDi>08806103500100</udiDi>
    <basicUdiDi>B-08806103500100</basicUdiDi>
    <tradeName>Atri Inj.</tradeName>
    <deviceName>Atri Inj. Sterile Absorbable Viscoelastic Solution (Sodium Hyaluronate Solution) for Arthritis</deviceName>
    <manufacturerName>YooYoung Pharmaceutical Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000017424</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ENPR237 / EPPR237 / TEPR237 / EAPR237</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:37:47.771Z</lastUpdated>
  </row>
  <row>
    <udiDi>08806103500070</udiDi>
    <basicUdiDi>B-08806103500070</basicUdiDi>
    <tradeName>Orthix Plus Inj.</tradeName>
    <deviceName>Orthix Plus Inj. Sterile Absorbable Viscoelastic Solution (Sodium Hyaluronate Solution) for Arthritis</deviceName>
    <manufacturerName>YooYoung Pharmaceutical Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000017424</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ENPR236 / TEPR236</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:37:39.367Z</lastUpdated>
  </row>
  <row>
    <udiDi>08806103500063</udiDi>
    <basicUdiDi>B-08806103500063</basicUdiDi>
    <tradeName>Orthix Inj.</tradeName>
    <deviceName>Orthix Inj. Sterile Absorbable Viscoelastic Solution (Sodium Hyaluronate Solution) for Arthritis</deviceName>
    <manufacturerName>YooYoung Pharmaceutical Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000017424</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ENPR237 / TEPR237</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:37:35.782Z</lastUpdated>
  </row>
</eudamedExport>